retatrutide clinical trials status 2025 Retatrutide, the next generation of GLP-1 drug from Eli Lilly, helped participants lose an average of 71.2 pounds and reduce knee arthritis pain in a late-stage trial, the company announced. In Retatrutide Promises Big Weight Loss,

Several studies have shown to reduce the overall body fat percentage, belly fat and blood triglycerides

Tesamorelin and Ipamorelin blend is a research compound sold for laboratory and research use only

Calorie intake: Started at 2,200 calories per day for 4 weeks Dropped to 2,000 calories for several weeks Final 10 days: 1,800 calories (this was horrible dont recommend) Protein intake: Averaged 175 grams per day throughout Training: Maintained 2-3 strength training sessions per week Added track and field work (sprints, jumps) Football once a week The protocol shift: After around 6 weeks on, I took 3-4 weeks off

AuNCs have dimensions between those of atoms and metallic NPs 33